From: The vital prognosis of elderly adults living in a group home in their mid-eighties
OPC (n = 57) | GH (n = 54) | p value | |
---|---|---|---|
Observation period, months | 55 (36–71) | 41 (23–72) | 0.111 |
Age, year | 82 (79–87) | 83 (78–90) | 0.351 |
Sex: male/female, n | 19/38 | 10/44 | 0.076 |
6-year mortality, % | 25 % | 50 % | 0.006 |
BMI, kg/m2 | 22.5 (18.9–25.0) | 20.0 (18.1–22.0) | 0.008 |
SBP, mmHg | 131 (119–149) | 120 (109–130) | 0.001 |
DBP, mmHg | 70 (60–80) | 70 (60–75) | 0.277 |
Cognitive function: categories 1/2/3 | 34/17/6 | 14/20/20 | <0.001 |
ADL score | 90 (63–100) | 60 (8–85) | <0.001 |
Medication | |||
EPA drug administration | 21 (37 %) | 33 (61 %) | 0.011 |
Other medications | |||
Antithrombotic agent | 25 (44 %) | 15 (28 %) | 0.049 |
Antihypertensive agent | 44 (77 %) | 30 (56 %) | 0.022 |
Diuretic or inotropic drug | 11 (19 %) | 20 (37 %) | 0.046 |
Antianginal drugs | 12 (21 %) | 4 (24 %) | 0.049 |
Anti-dementia agent | 6 (11 %) | 13 (7 %) | 0.067 |
Hypoglycemic agent | 7 (12 %) | 4 (30 %) | 0.247 |
Dyslipidemia medication | 17 (30 %) | 16 (2 %) | 0.935 |
Antiarrhythmic agent | 7 (12 %) | 1 (7 %) | 0.018 |